Lucas Otieno Tina

Victoria Biomedical Research Institute (VIBRI) is a prominent African health research organization headquartered in Kisumu, Kenya. Founded and led by Dr. Lucas Otieno Tina, the institute specializes in the design and execution of clinical trials for vaccines, therapeutics, and medical devices, with a primary focus on infectious diseases such as malaria, COVID-19, and tuberculosis. VIBRI operates an extensive network of clinical research sites and maintains strategic partnerships with global health leaders, including PATH, GSK, Sanofi, and the Bill & Melinda Gates Foundation. The institute played a critical role in the landmark Phase 3 trials of the RTS,S malaria vaccine and continues to lead high-impact research aimed at improving health outcomes in the East and Central Africa region. As a center of excellence, VIBRI is dedicated to accelerating the development of innovative medical solutions while building local research capacity to international standards.